Authors


Onyi Okeke, MD

Latest:

Breaking the Silence: Unleashing the Power of Emotions in the Fight Against Anti-Black Racism in Mental Health Services

Here’s why you should attend the Yale Child Study Center Black Youth Mental Health Case Conference.


Heba Mesbah, MD, PhD

Latest:

Agitation Assessment: The Role of Psychiatry in Acute Settings

How can agitation mimic various psychiatric illnesses?


Aliza Vigderman

Latest:

Increased Internet Usage and Cyberbullying

What can you do to prevent a child from being cyberbullied? Here are some tips from security expert, Aliza Vigderman at Security.org.



Husein Hijazi, MD

Latest:

The Slow Road to Psychosis

Take a look at the differentiation between prodrome and attenuated psychosis, along with cognitive impairment associated with schizophrenia.


Darby J.E. Lowe, MSc

Latest:

Dual Diagnosis: Double the Stigma, Double the Trouble

Understanding the additive effects of stigma surrounding dual diagnosis with both substance use disorder and a mental illness.


Shervin Shadianloo, MD

Latest:

The Negative Impact of Current Legislation on Gender Diverse Adolescents

Due to discrimination's negative impact, transgender and gender-nonconforming youth are several times more likely than the rate of their cisgender peers to have depression and anxiety.


Sarah Fleming

Latest:

Science and Art in Cognitive Behavioral Therapy

"The root of the word 'create' or 'creativity' essentially means 'to grow.' That is probably what lies at the heart of what patients really want; they want to grow in terms of their relationships, their abilities, their passions and interests, their health, and in terms of whatever dreams they want to achieve personally in their lives."


Justin Allen, MD

Latest:

Clinical Features Associated With Response to Ketamine vs Electroconvulsive Therapy for Treatment-Resistant Depression

Ketamine or ECT? A new study reveals which works best for severe depression—depending on the patient and setting.



Joshua Feder, MD, DFAPA

Latest:

Discontinuing Antipsychotics

What is the appropriate duration for antipsychotic use and how can you safely taper or discontinue them?




David Scharff, MD, FABP

Latest:

Our Work and What the Award Means to Us: 2021 Sigourney Award Winners

These 2 Sigourney Award Winners share their journey to success.


Abigail Jaeger, MD

Latest:

Zuranolone for the Treatment of Adults With Major Depressive Disorder

This randomized, placebo-controlled, phase 3 clinical trial showed that a 14-day treatment course of oral zuranolone 50 mg/day in MDD led to significantly greater improvements in depressive symptoms when compared with placebo.



Seth Feuerstein, MD, JD

Latest:

The Expanding Role of Digital Therapeutics in Mental Health

What products have broken ground in the digital therapeutics space, and how can they help patients?


Raina Aggarwal, MD

Latest:

Issues in Civil Commitment: The Cases of Incarcerated Patients

There are several points along this pathway for a justice involved patient to be intercepted and diverted to mental health treatment.


Adriane Bennett, PhD

Latest:

Benzodiazepine Use and the Risk of Dementia

Nearly half of the prescriptions for benzodiazepine among older adults are potentially inappropriate, so how best to do no harm?


Dwight E. Kemp, MD, MS

Latest:

Family. Food. Faith.

“We hold on to the promise because it continues to sustain us… and me.”


Tabark Altai, MD

Latest:

The Hidden Suffering of Social Anxiety Disorder

Social anxiety disorder: increased screening and recognition are essential for proper diagnosis, and psychotropic and psychotherapeutic options can be effective.


Paul M. Grant, PhD

Latest:

Recovery-Oriented Cognitive Therapy: Changing Lives With a Whole-Person Approach

Are you ready to understand how recovery-oriented cognitive therapy (CT-R) promotes wellness and empowerment for individuals experiencing serious mental health challenges? Check out this CME article.


Charles Upchurch

Latest:

Physicians and Friends Find Healing and Purpose in The Ride for Mental Health

“The pervasive feeling shared by all is that regardless of your personal journey and experiences with mental health, you are not alone.”


Pallavi Joshi, DO, MA

Latest:

Can Semaglutide Help in Psychiatry Too? Research Shows Promise for AD and PD

Available evidence from preclinical studies indicates that semaglutide shows promise for treating Alzheimer disease and Parkinson disease.


Anne Williams-Wengerd, MA, LP

Latest:

Promoting Resiliency After First-Episode Psychosis

Simple but powerful strategies for drawing on patients’ existing character strengths and long-term goals.


Thomas Strouse, MD

Latest:

End-of-Life Care for Patients With Psychiatric Disorders

In this CME article, learn how best to provide end-of-life care to patients with psychiatric disorders.


Cassandra L. Boness, PhD

Latest:

Nonabstinent Recovery From Alcohol Use Disorder

"Limiting definitions of recovery to abstinence and the absence of AUD symptoms fail to capture the multidimensional and heterogeneous pathways to recovery that research has shown to exist among both treatment-seeking and population samples."


Daniel Pick, PhD

Latest:

In Conversation With a Sigourney Award Winner: The Intersection of History, Humanities, and Psychoanalytic Thought

“Freudian thought has massively influenced not only modern understandings of mind and therapeutic treatment, but also modernism and many distinct visions of politics.”


Honor Hsin, MD, PhD

Latest:

Delivering Health Care Through Digital Mental Health Ecosystems

Here’s how a digital mental health ecosystem can seamlessly connect and support all facets of mental health care.


Timothy Mariano, MD, PhD, MSc

Latest:

Mental Health in America: A Growing Crisis

What are the greatest unmet mental health needs in the United States today? Recent statistics from the Centers for Disease Control may hold the answers.

© 2025 MJH Life Sciences

All rights reserved.